Paul G. Richardson, MD, on Multiple Myeloma and COVID-19: An Update

July 14, 2021 By The ASCO Post Staff

Paul G. Richardson, MD, of Dana-Farber Cancer Institute, discusses challenges patients with multiple myeloma have faced as a result of the COVID-19 pandemic and the research he and his international colleagues are conducting to better understand these difficulties and improve patient care.

Related Content